RALEIGH, N.C., Sept. 26, 2013 /PRNewswire/ -- STEPh, Inc., a full service medical communications company, is pleased to make available their latest electronic version of Investigational Agents in Development for Multiple Sclerosis. The 343 page report provides a critical review of 68 development programs, preclinical through NDA, and includes links to original source documents and publications. This report, quarterly updates, and accompanying materials are available from the Company's web site (http://www.stephreports.com/).
About STEPh Reports
Each STEPh Report assesses the competitive landscape by individual drug monograph, MOA, clinical trials data, projected launch year, company, and specific key issues. STEPh Reports are written by individuals with expertise in clinical pharmacology and knowledge of drug development processes. Reports are reviewed by subject matter experts. STEPh Reports are updated quarterly and are fully referenced, including links to original source documents. Complementary features to STEPh Reports include daily and archival news, pipeline tables, mini reviews of Hot Topics, and links to key resources. A Q&A service is also available.
About MS STEPh Report
The MS Report assesses the competitive landscape by drug monograph, MOA, clinical data, projected launch year, company, and key issues.
Table of Contents
- Topline Summary
- Oral Agents
- S1P Agonists
- Vaccines, Interferons
- Agents Part of Combination or vs. Active Comparator
- Agents for CIS, PPMS, and SPMS
- Generic Copaxone and Alternative Glatiramer Formulations
- Agents for NMO
- Licensing Candidates
- Companies Involved in MS Research
- Individual (68) Drug Monographs
Purchasing MS Report
Individuals (clinicians, pharmacists, nurses, physical therapists, students) can purchase the report and CI service for a nominal charge. Corporate subscriptions are also available and include an unlimited number of seats per Therapeutic Area. Please contact Dr. Bauman (as noted below) for more information.
Other Services Offered by STEPh, Inc.
Medical Writing—manuscripts, abstracts, posters, product monographs, training materials. STEPh, Inc., has an impeccable track record for manuscript acceptance in peer review journals,.
Medical Information—creation of standard response letters, support for product launches. Dr. Bauman has been a Medical Information practitioner for over 30 years.
About STEPh, Inc.
STEPh, Inc., was formed in 2005 by pharmaceutical industry veterans. Dr. Bauman is accomplished author, former Editor of Hospital Edition--US Pharmacist, and founding member of Medical Communications subgroup of DIA.
SOURCE Scientific and Technical Evaluation of Pharmaceuticals, Inc.